Speciality European Pharma (Mitem) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
2
Speciality European Pharma (Mitem) General Information
Description
Rights of a bladder cancer product.
Contact Information
Corporate Office
- London
- England, United Kingdom
Corporate Office
- London
- England, United Kingdom
Speciality European Pharma (Mitem) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Speciality European Pharma (Mitem) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Speciality European Pharma (Mitem) FAQs
-
Where is Speciality European Pharma (Mitem) headquartered?
Speciality European Pharma (Mitem) is headquartered in London, United Kingdom.
-
What industry is Speciality European Pharma (Mitem) in?
Speciality European Pharma (Mitem)’s primary industry is Buildings and Property.
-
Is Speciality European Pharma (Mitem) a private or public company?
Speciality European Pharma (Mitem) is a Private company.
-
What is Speciality European Pharma (Mitem)’s current revenue?
The current revenue for Speciality European Pharma (Mitem) is .
-
Who are Speciality European Pharma (Mitem)’s investors?
Contura has invested in Speciality European Pharma (Mitem).
-
When was Speciality European Pharma (Mitem) acquired?
Speciality European Pharma (Mitem) was acquired on 27-Apr-2017.
-
Who acquired Speciality European Pharma (Mitem)?
Speciality European Pharma (Mitem) was acquired by Substipharm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process